Tri K. Nguyen

553 total citations
10 papers, 460 citations indexed

About

Tri K. Nguyen is a scholar working on Hematology, Molecular Biology and Rheumatology. According to data from OpenAlex, Tri K. Nguyen has authored 10 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Tri K. Nguyen's work include Chronic Myeloid Leukemia Treatments (7 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Tri K. Nguyen is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Tri K. Nguyen collaborates with scholars based in United States, Canada and Russia. Tri K. Nguyen's co-authors include Steven Grant, Paul Dent, Mohamed Rahmani, Hisashi Harada, Shuang Chen, Yun Dai, Charis A. Venditti, Xin‐Yan Pei, Girija Dasmahapatra and Richard I. Fisher and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Tri K. Nguyen

10 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tri K. Nguyen United States 8 274 136 108 99 83 10 460
Kerstin Maria Kampa-Schittenhelm Germany 12 283 1.0× 155 1.1× 40 0.4× 171 1.7× 80 1.0× 30 516
Sho Kubota Japan 16 369 1.3× 97 0.7× 74 0.7× 122 1.2× 29 0.3× 46 552
Laura Quotti Tubi Italy 10 275 1.0× 118 0.9× 39 0.4× 114 1.2× 98 1.2× 21 411
Sherif Ibrahim United States 6 328 1.2× 132 1.0× 35 0.3× 97 1.0× 42 0.5× 6 459
Ryan A. Denu United States 10 270 1.0× 98 0.7× 153 1.4× 155 1.6× 55 0.7× 24 502
Richard Monni France 8 305 1.1× 244 1.8× 31 0.3× 200 2.0× 93 1.1× 8 603
Akiko Sakashita Japan 11 481 1.8× 227 1.7× 30 0.3× 108 1.1× 39 0.5× 30 658
Giulia Orlando Italy 10 322 1.2× 32 0.2× 25 0.2× 121 1.2× 47 0.6× 30 484
Lourdes Mendez United States 10 309 1.1× 104 0.8× 31 0.3× 218 2.2× 112 1.3× 34 609
Sourik S. Ganguly United States 10 244 0.9× 75 0.6× 26 0.2× 142 1.4× 21 0.3× 15 403

Countries citing papers authored by Tri K. Nguyen

Since Specialization
Citations

This map shows the geographic impact of Tri K. Nguyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tri K. Nguyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tri K. Nguyen more than expected).

Fields of papers citing papers by Tri K. Nguyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tri K. Nguyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tri K. Nguyen. The network helps show where Tri K. Nguyen may publish in the future.

Co-authorship network of co-authors of Tri K. Nguyen

This figure shows the co-authorship network connecting the top 25 collaborators of Tri K. Nguyen. A scholar is included among the top collaborators of Tri K. Nguyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tri K. Nguyen. Tri K. Nguyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nguyen, Tri K. & Steven Grant. (2013). Dinaciclib (SCH727965) Inhibits the Unfolded Protein Response through a CDK1- and 5-Dependent Mechanism. Molecular Cancer Therapeutics. 13(3). 662–674. 34 indexed citations
2.
3.
Nguyen, Tri K., et al.. (2010). Inhibition of MEK/ERK1/2 sensitizes lymphoma cells to sorafenib-induced apoptosis. Leukemia Research. 34(3). 379–386. 22 indexed citations
4.
Dai, Yun, Shuang Chen, Charis A. Venditti, et al.. (2008). Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate. Blood. 112(3). 793–804. 51 indexed citations
5.
6.
Nguyen, Tri K., Mohamed Rahmani, Hisashi Harada, Paul Dent, & Steven Grant. (2007). MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825. Blood. 109(9). 4006–4015. 49 indexed citations
7.
Rahmani, Mohamed, et al.. (2007). The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress. Molecular and Cellular Biology. 27(15). 5499–5513. 198 indexed citations
8.
Dai, Yun, Shuang Chen, Charis A. Venditti, et al.. (2007). Vorinostat Synergistically Potentiates MK-0457 Lethality in Chronic Myelogenous Leukemia (CML) Cells Sensitive and Resistant to Imatinib Mesylate.. Blood. 110(11). 1041–1041. 3 indexed citations
9.
Nguyen, Tri K., Mohamed Rahmani, Ning Gao, et al.. (2006). Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl+ Leukemia Cells Sensitive and Resistant to Imatinib Mesylate. Clinical Cancer Research. 12(7). 2239–2247. 20 indexed citations
10.
Dasmahapatra, Girija, Tri K. Nguyen, Paul Dent, & Steven Grant. (2006). Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl. Leukemia Research. 30(10). 1263–1272. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerstin Maria Kampa-Schittenhelm Breakdown of academic impact, for papers by Sho Kubota Breakdown of academic impact, for papers by Laura Quotti Tubi Breakdown of academic impact, for papers by Sherif Ibrahim Breakdown of academic impact, for papers by Ryan A. Denu Breakdown of academic impact, for papers by Richard Monni Breakdown of academic impact, for papers by Akiko Sakashita Breakdown of academic impact, for papers by Giulia Orlando Breakdown of academic impact, for papers by Lourdes Mendez Breakdown of academic impact, for papers by Sourik S. Ganguly
Rankless by CCL
2026